Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

By L. Norgren, W. Hiatt, J. Dormandy, M. Nehler, K. Harris, F. Fowkes. Journal of Vascular Surgery, 2007

6,901 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “Strict blood pressure control often fails to improve ischemic symptoms in the lower limbs, but is quite important for preventing cardiovascular events along with the control of risk factors including smoking cessation [1084].”
Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, methodology): “Although the TASC II document did not include LS in the treatment of CLTI, it did mention its potential role in the management of complex regional pain syndrome.(156) The ESVS guidelines conclude that LS should not be considered an option to prevent amputation but can be considered in patients who a”
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. (2015, methodology): “The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) working group recommended patients treated with lower extremity vein grafts be monitored for at least 2 years with a clinical surveillance program that consists of an interval history to detect new symptoms, puls”